Newsletter Signup | Join Community | Cancer Types
Vidaza® May Provide Alternative Treatment for Elderly Patients with AML.
Asciminib shows superior responses compared to Bosulif for treatment of chronic myeloid leukemia.
Connect with Others at Top Cancer Centers - Second Opinion Options...
Studies continue to demonstrate that incorporation of Blincyto into ALL treatment improves patient outcomes.
Venclexta® expands treatment options for AML - ASCO 2020 update in elderly AML patients confirms benefit.
FDA Approves Venclexta, Daurismo, and Xospata Precision Cancer Medicines for Treatment of Acute Myeloid Leukemia
Brukinsa is a novel BTK inhibitor with encouraging anti-cancer activity in the management of CLL/SLL.
Zanubrutinib, obinutuzumab, venetoclax (BOVen) promising new treatment for Chronic Lymphocytic Leukemia and lymphomas.
Sustained progression free and overall survival benefits with Venclexta combined with Rituxan or Imbruvica.
Calquence side effects
considering CAR T for ALL - anyone been through it yet?
looking for others to share their experience with stem cell transplant for leukemia.